These lab-created alternatives were not formulated with leisure use in mind. While in the nineties, John W. Huffman and a workforce of fellow chemists at Clemson College developed several of the very first formulation for synthetic cannabinoid receptor agonists (SCRAs), a family members of substances that imitate the physiological and psychological